William Prentice

William Prentice has extensive experience in leadership and finance, currently serving as President & CEO of Signati Medical Inc. since November 2018 and as Principal at Prentice & Associates since January 2015. Previously, William held senior roles at NASDAQ OMX, including Senior Managing Director from September 2013 to April 2014 and again from September 2002 to November 2003. Additional experience includes serving as an Equity Trader at Stifel, Nicolaus & Company, Incorporated from December 2003 to June 2009 and as a Senior Trader at BNY Mellon | Pershing from December 1992 to October 2002, while working with the data storage group at NASDAQ OMX.